Literature DB >> 12620453

Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor.

Makio Shozu1, Kouichi Murakami, Tomoya Segawa, Tadayuki Kasai, Masaki Inoue.   

Abstract

OBJECTIVE: To assess the management of symptomatic leiomyomas using a nonsteroidal aromatase inhibitor in perimenopausal women.
DESIGN: Case report.
SETTING: Academic clinical practice. PATIENT(S): A 53-year-old woman suffering from recurrent urinary retention secondary to a uterine leiomyoma. INTERVENTION(S): Fadrozole, orally, 2 mg daily for 8 weeks and then 1 mg daily for 4 weeks. MAIN OUTCOME MEASURE(S): Measurements of leiomyoma volume, and levels of serum E(2), LH, and FSH. RESULT(S): Urinary retention resolved after 2 weeks of treatment and did not recur. Leiomyoma volume estimated by ultrasonography revealed a 71% reduction after 8 weeks of treatment. CONCLUSION(S): Fadrozole was useful for the management of a symptomatic leiomyoma without transient deterioration of symptoms. Clinical trials are warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620453     DOI: 10.1016/s0015-0282(02)04761-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Benign metastasising leiomyoma: a progressive disease despite chemical and surgical castration.

Authors:  Inês Silva; Vera Tomé; João Oliveira
Journal:  BMJ Case Rep       Date:  2012-03-27

Review 2.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

3.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 4.  Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.

Authors:  Clara Q Wu; Guylaine Lefebvre; Helena Frecker; Heinrich Husslein
Journal:  Int Urogynecol J       Date:  2015-03-10       Impact factor: 2.894

Review 5.  Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.

Authors:  Molly B Moravek; Serdar E Bulun
Journal:  Curr Opin Obstet Gynecol       Date:  2015-08       Impact factor: 1.927

6.  Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.

Authors:  Mostafa A Borahay; Gokhan S Kilic; Chandrasekha Yallampalli; Russell R Snyder; Gary D V Hankins; Ayman Al-Hendy; Darren Boehning
Journal:  J Biol Chem       Date:  2014-10-30       Impact factor: 5.157

Review 7.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

Review 8.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Authors:  Molly B Moravek; Ping Yin; Masanori Ono; John S Coon; Matthew T Dyson; Antonia Navarro; Erica E Marsh; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2014-09-08       Impact factor: 15.610

Review 9.  Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review.

Authors:  Erin I Lewis; Rebecca J Chason; Alan H DeCherney; Alicia Armstrong; John Elkas; Aradhana M Venkatesan
Journal:  Fertil Steril       Date:  2013-03-05       Impact factor: 7.329

10.  Heavy menstrual flow: current and future trends in management.

Authors:  Yusuf Beebeejaun; Rajesh Varma
Journal:  Rev Obstet Gynecol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.